November 13, 2018 (Investorideas.com Newswire) The common shares of Ovation Science Inc., have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading date.
Ovation Science Inc. is engaged in the business of sublicensing rights to use Invisicare a patented drug delivery technology used in topical and transdermal skin products containing hemp seed oil and cannabis products.
________________________
Les actions ordinaires de Ovation Science Inc. ont été approuvées pour être inscrites à la cote de la CST.
Les documents de cotation et d’information seront disponibles sur www.thecse.com à la date de négociation.
Ovation Science Inc est engagée dans la sous-licence de droits d’utilisation d’Invisicare, une technologie brevetée d’administration de médicaments utilisée dans les produits topiques et transdermiques pour la peau contenant de l’huile de graines de chanvre et des produits à base de cannabis.
The Exchange is accepting Market Maker applications for OVAT. Please email: Trading@theCSE.com
If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com
Pour toute question, pour obtenir de l’information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l’adresse: Listings@thecse.com
Investorideas.com is a Canadian Securities Exchange (CSE) Service Provider; Cannabis stocks, Blockchain stocks, Mining, E-sports, Energy, Biotech and more…
The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004; the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets. http://thecse.com/
Marijuana / Hemp Stocks info for investors
This news is published on the Investorideas.com Newswire – a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 – all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
